INTERCEPT PHARMACEUTICALS IN

CUSIP: 45845P108 Class: Common Stock

HOLLENCREST CAPITAL MANAGEMENT's Holding History (CIK: 0001161722)

Note: Option positions (PUT/CALL) are excluded.

Q3 2023
Shares 15,000 Value ($000) $278 Avg Close — Range —
Q2 2023
Shares 15,000 Value ($000) $166 Avg Close — Range —
Q1 2023
Shares 15,000 Value ($000) $201 Avg Close — Range —
Q4 2022
Shares 15,000 Value ($000) $186 Avg Close — Range —